These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 8314410)

  • 1. On the sequential design of the Deutsche Nikotinamid Interventionsstudie--DENIS.
    Haastert B; Giani G
    Diabete Metab; 1993; 19(1 Pt 2):100-4. PubMed ID: 8314410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention with nicotinamide in pre-type 1 diabetes: the Deutsche Nikotinamid Interventionsstudie-DENIS.
    Lampeter EF
    Diabete Metab; 1993; 19(1 Pt 2):105-9. PubMed ID: 8314411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
    Lampeter EF; Klinghammer A; Scherbaum WA; Heinze E; Haastert B; Giani G; Kolb H
    Diabetes; 1998 Jun; 47(6):980-4. PubMed ID: 9604880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of type 1a diabetes mellitus*.
    Wilson DM; Buckingham B
    Pediatr Diabetes; 2001 Mar; 2(1):17-24. PubMed ID: 15016206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [European Nicotinamide Diabetes Intervention Trial (ENDIT)--secondary publication. A randomized, placebo-controlled trial of intervention before the onset of type 1 diabetes].
    Reimers JI; Larsen CM; Mandrup-Poulsen TR;
    Ugeskr Laeger; 2005 Jan; 167(3):293-6. PubMed ID: 15704800
    [No Abstract]   [Full Text] [Related]  

  • 7. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sequential analysis in clinical and epidemiological research].
    van der Tweel I; Schipper M
    Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2348-52. PubMed ID: 12510397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention.
    Pozzilli P
    Diabetes Metab Res Rev; 2002; 18(4):257-9. PubMed ID: 12203941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
    Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting an interim analysis procedure.
    Overall JE; Atlas RS
    Psychopharmacol Bull; 1993; 29(2):141-7. PubMed ID: 8290658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing pains in the pursuit of diabetes prevention.
    Wang PH
    Lancet; 2004 Mar; 363(9413):910. PubMed ID: 15043953
    [No Abstract]   [Full Text] [Related]  

  • 19. [Info-congress. Study of the prevention of type 1 diabetes with nicotinamide: positive lessons of a negative clinical trial (ENDIT)].
    Philips JC; Scheen AJ;
    Rev Med Liege; 2002 Oct; 57(10):672-5. PubMed ID: 12481473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide and diabetes prevention.
    Behme MT
    Nutr Rev; 1995 May; 53(5):137-9. PubMed ID: 7666987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.